Down syndrome

Reading File
Finding Sources
Searching PubMed

"Down syndrome"[MeSH Terms]

Searching Images

Down syndrome trisomy 21 karyotype facial features

A composite figure illustrating the historical and genetic context of Down syndrome (Trisomy 21). Panel A shows a portrait of John Langdon Down, who first described the clinical features. Panel B is a black-and-white clinical photograph of two individuals; the male exhibits characteristic dysmorphic facial features of Down syndrome, including upslanting palpebral fissures, epicanthic folds, and a flattened nasal bridge. Panel C depicts Dr. Jérôme Lejeune, the geneticist who identified the chromosomal basis of the condition. Panel D shows a spectral karyotype (SKY) or multicolor fluorescence in situ hybridization (m-FISH) arrangement. All autosomal pairs are numbered 1 through 22, along with X and Y sex chromosomes. A pink arrow highlights the genetic hallmark of the disorder: three copies of chromosome 21 (Trisomy 21) instead of the typical homologous pair. This educational graphic links clinical phenotype with its underlying cytogenetic pathology, suitable for medical genetics and pediatrics curricula.

A composite figure illustrating the historical and genetic context of Down syndrome (Trisomy 21). Panel A shows a portrait of John Langdon Down, who first described the clinical features. Panel B is a black-and-white clinical photograph of two individuals; the male exhibits characteristic dysmorphic facial features of Down syndrome, including upslanting palpebral fissures, epicanthic folds, and a flattened nasal bridge. Panel C depicts Dr. Jérôme Lejeune, the geneticist who identified the chromosomal basis of the condition. Panel D shows a spectral karyotype (SKY) or multicolor fluorescence in situ hybridization (m-FISH) arrangement. All autosomal pairs are numbered 1 through 22, along with X and Y sex chromosomes. A pink arrow highlights the genetic hallmark of the disorder: three copies of chromosome 21 (Trisomy 21) instead of the typical homologous pair. This educational graphic links clinical phenotype with its underlying cytogenetic pathology, suitable for medical genetics and pediatrics curricula.

Clinical photograph of a 15-year-old female patient exhibiting phenotypic facial features characteristic of Down syndrome (Trisomy 21). The image demonstrates a flattened facial profile with a notably low-set and depressed nasal bridge. Ocular findings include upslanting palpebral fissures and prominent bilateral epicanthic folds (medial epicanthal skin folds) covering the inner canthi. Additional craniofacial features include a relatively small oral cavity and mild brachycephaly. The patient has light skin with fine freckling across the midface. This image serves as a teaching tool for medical genetics and clinical pediatrics, illustrating the classic dysmorphic facial features associated with Trisomy 21 in an adolescent. The clinical context suggests an association with Morning Glory Syndrome (MGS), though the internal ocular pathologies are not visible in this external facial view.

Clinical photograph of a 15-year-old female patient exhibiting phenotypic facial features characteristic of Down syndrome (Trisomy 21). The image demonstrates a flattened facial profile with a notably low-set and depressed nasal bridge. Ocular findings include upslanting palpebral fissures and prominent bilateral epicanthic folds (medial epicanthal skin folds) covering the inner canthi. Additional craniofacial features include a relatively small oral cavity and mild brachycephaly. The patient has light skin with fine freckling across the midface. This image serves as a teaching tool for medical genetics and clinical pediatrics, illustrating the classic dysmorphic facial features associated with Trisomy 21 in an adolescent. The clinical context suggests an association with Morning Glory Syndrome (MGS), though the internal ocular pathologies are not visible in this external facial view.

This composite clinical photograph displays the postnatal morphological features of a fetus with trisomy 21 (Down syndrome). Panel A provides a facial profile view illustrating several classic dysmorphic features, including a flat facial profile, telecanthus/hypertelorism (widely spaced eyes), a markedly depressed nasal bridge, and macroglossia resulting in a protruding tongue. Panel B shows the right hand of the fetus being examined with surgical forceps, highlighting a single transverse palmar crease (simian crease), a common soft marker associated with various chromosomal abnormalities. The images are set against a blue background with a metric ruler for scale, typical of a clinical pathology or autopsy setting. These findings serve as physical manifestations of the underlying genetic duplication of 21q22.12-q22.3, which includes critical regions associated with the Down syndrome phenotype.

This composite clinical photograph displays the postnatal morphological features of a fetus with trisomy 21 (Down syndrome). Panel A provides a facial profile view illustrating several classic dysmorphic features, including a flat facial profile, telecanthus/hypertelorism (widely spaced eyes), a markedly depressed nasal bridge, and macroglossia resulting in a protruding tongue. Panel B shows the right hand of the fetus being examined with surgical forceps, highlighting a single transverse palmar crease (simian crease), a common soft marker associated with various chromosomal abnormalities. The images are set against a blue background with a metric ruler for scale, typical of a clinical pathology or autopsy setting. These findings serve as physical manifestations of the underlying genetic duplication of 21q22.12-q22.3, which includes critical regions associated with the Down syndrome phenotype.

Clinical photograph of a pediatric patient exhibiting characteristic dysmorphic facial features and ophthalmologic abnormalities associated with Down syndrome (Trisomy 21). The image primarily demonstrates bilateral congenital ectropion of the upper eyelids, characterized by an outward eversion of the lid margins and exposure of the palpebral conjunctiva. Other visible craniofacial findings include bilateral epicanthal folds (skin folds covering the medial canthus), a flattened nasal bridge, and midface hypoplasia. There is also evident periorbital edema and an upward slanting of the palpebral fissures. This visual case illustrates the rare manifestation of congenital upper lid ectropion in the context of anterior lamellar shortening and general horizontal lid laxity. The photograph is essential for teaching neonatal and pediatric ophthalmology diagnostic signs and the phenotypic spectrum of Trisomy 21.

Clinical photograph of a pediatric patient exhibiting characteristic dysmorphic facial features and ophthalmologic abnormalities associated with Down syndrome (Trisomy 21). The image primarily demonstrates bilateral congenital ectropion of the upper eyelids, characterized by an outward eversion of the lid margins and exposure of the palpebral conjunctiva. Other visible craniofacial findings include bilateral epicanthal folds (skin folds covering the medial canthus), a flattened nasal bridge, and midface hypoplasia. There is also evident periorbital edema and an upward slanting of the palpebral fissures. This visual case illustrates the rare manifestation of congenital upper lid ectropion in the context of anterior lamellar shortening and general horizontal lid laxity. The photograph is essential for teaching neonatal and pediatric ophthalmology diagnostic signs and the phenotypic spectrum of Trisomy 21.

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
I now have comprehensive information from multiple authoritative textbooks. Let me compile the full answer.

Down Syndrome (Trisomy 21)

Overview

Down syndrome is the most common chromosomal disorder and the single most common genetic cause of moderate intellectual disability, with an incidence of approximately 1 in 700 live births in the United States. It arises from an extra copy of chromosome 21, producing a triple gene dosage that disrupts development across multiple organ systems.
  • Robbins & Cotran Pathologic Basis of Disease, p. 163
  • Thompson & Thompson Genetics and Genomics in Medicine, 9th ed., p. 103

Cytogenetics: Three Mechanisms

TypeFrequencyKaryotypeMaternal Age Effect
Trisomy 21 (free)~95%47,XX or XY,+21Yes - strong
Robertsonian translocation~4%46 chromosomes (21q fused to chr 14 or 22)No
Mosaic~1-2%Mix of 46 and 47 chromosome cellsNo
Free Trisomy 21: Results from meiotic nondisjunction - the chromosome 21 pair fails to separate. In ~90% of cases the error is maternal, predominantly in meiosis I. Maternal age is the dominant risk factor: incidence rises from 1 in 1,550 births at age <20 to 1 in 25 births at age >45.
Robertsonian Translocation: The long arm of chromosome 21 fuses to another acrocentric chromosome (usually 14). The patient has 46 chromosomes but is functionally trisomic for 21q. This type can be familial - a parent carrying a balanced Robertsonian translocation (karyotype 45,XX,del(14;21)(q10;q10)) has a significantly elevated recurrence risk, which is why karyotyping is essential.
Mosaicism: Results from mitotic nondisjunction during early embryogenesis. Phenotype is often milder and more variable depending on the proportion of trisomic cells.
  • Thompson & Thompson Genetics, p. 103-104
  • Robbins, p. 162-163

FISH Confirmation of Trisomy 21

Below: Fluorescence in situ hybridization (FISH) of an interphase nucleus with chromosome 13 (green) and chromosome 21 (red) probes. Three red signals confirm trisomy 21.
FISH showing 3 chromosome 21 signals (red) confirming trisomy 21

Clinical Features

Facial & Physical

  • Flat facial profile, oblique (upslanting) palpebral fissures, epicanthic folds
  • Brachycephaly with flat occiput; short neck with loose nape skin
  • Short, broad hands; single transverse palmar crease (simian crease); fifth-finger clinodactyly
  • Short stature; hypotonia (often the first sign in the newborn)
Characteristic facial features of Down syndrome

Cognitive

  • Intellectual disability ranging from mild to moderate
  • Delay typically becomes obvious by end of the first year
  • Wide variability - many individuals attend school and develop partial self-reliance
  • Mosaics can have near-normal intelligence

Cardiac (present in ~40-50%)

The most common cause of death in infancy:
  • Atrioventricular septal defects (43%)
  • Ventricular septal defects (32%)
  • Atrial septal defects (19%)
  • Tetralogy of Fallot (6%)

Gastrointestinal

  • Duodenal atresia and tracheoesophageal fistula occur at much higher rates than in the general population
  • Esophageal atresia and small bowel atresias also reported

Hematologic / Oncologic

  • 20-fold increased risk of precursor B-cell ALL
  • 500-fold increased risk of acute myeloid leukemia (particularly acute megakaryoblastic leukemia)
  • Transient myeloproliferative disorder (TMD): Up to 10% of neonates with Down syndrome develop peripheral blood leukocytosis with blasts; TMD usually resolves spontaneously but progresses to acute megakaryoblastic leukemia in 23-30% of cases. Driven by acquired GATA1 mutations during fetal life.

Neurological / Alzheimer Disease

  • Virtually all patients with trisomy 21 older than age 40 develop neuropathologic changes of Alzheimer disease (cortical atrophy, neurofibrillary tangles, amyloid plaques)
  • This is explained by triplication of the APP gene on chromosome 21 - overproduction of amyloid precursor protein leads to early amyloid-beta accumulation

Immune

  • Abnormal T-cell function predisposes to serious pulmonary infections
  • Increased risk of thyroid autoimmunity
  • Robbins, p. 163-164
  • Goldman-Cecil Medicine

Molecular Pathogenesis

Three key mechanisms underlie the phenotype (gene dosage effects rather than a single culprit gene):
  1. Gene overexpression - most protein-coding genes on chr 21 are overexpressed ~1.5x, including APP (Alzheimer risk) and genes regulating hematopoiesis (GATA1 pathway)
  2. Mitochondrial dysfunction - ~10% of overexpressed genes regulate mitochondrial function; mitochondria show abnormal cristae, reactive oxygen species generation, and increased apoptosis
  3. Noncoding RNAs - chromosome 21 has the highest density of long noncoding RNAs (lncRNAs) of any chromosome; their roles are still being characterized

Prenatal Diagnosis

  • Cell-free fetal DNA (cfDNA) / NIPT: ~5-10% of cell-free DNA in maternal blood is fetal; next-generation sequencing of chromosome 21 gene dosage is a powerful non-invasive screening tool
  • Positive screens should be confirmed by conventional karyotyping from chorionic villus sampling (CVS) or amniocentesis
  • Karyotyping is also essential to distinguish free trisomy from translocation type (different recurrence risk and genetic counseling implications)

Prognosis & Longevity

Improved medical care has significantly extended survival. The median age at death was 25 years in 1983; it is now 47 years. Congenital heart disease and respiratory infections remain leading causes of early death.

Recent Evidence (2024-2026)

Two recent systematic reviews are relevant:
  • Alzheimer biomarkers: Blood-based biomarkers for Alzheimer disease in Down syndrome were reviewed in a 2025 meta-analysis (PMID 40219863), identifying promising plasma phospho-tau and amyloid markers for earlier detection
  • Respiratory support: A 2025 systematic review (PMID 39909501) examined respiratory complications and support strategies, reinforcing that lung disease remains a major morbidity
This is a shared conversation. Sign in to Orris to start your own chat.